Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Doxycycline Capsules, 40 mg is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
It is the first autotaxin inhibitor to be investigated in cancer patients
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Sustainability is integral to Biocon's business purpose
Subscribe To Our Newsletter & Stay Updated
